---
title: "FRKJ: The company has developed high-performance aluminum alloy materials for MR/AR/AI glasses"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229155799.md"
description: "FRKJ stated on the interactive platform that the company has developed high-performance aluminum alloy materials for MR/AR/AI glasses, which have been applied to actual products of terminal brand customers"
datetime: "2025-02-21T08:48:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229155799.md)
  - [en](https://longbridge.com/en/news/229155799.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229155799.md)
generator: "portal-rs"
---

# FRKJ: The company has developed high-performance aluminum alloy materials for MR/AR/AI glasses

FRKJ stated on the interactive platform that the company has developed high-performance aluminum alloy materials for MR/AR/AI glasses, which have been applied to the actual products of terminal brand customers

### Related Stocks

- [603327.CN](https://longbridge.com/en/quote/603327.CN.md)

## Related News & Research

- [COSCO SHIPPING: Revenue up 2.6%, net profit down 23.6%, interim dividend RMB0.43 per share](https://longbridge.com/en/news/297342819.md)
- [Gentian Diagnostics to attend PReS meeting, spotlight circulating calprotectin testing in pediatric rheumatology](https://longbridge.com/en/news/297638164.md)
- [08:38 ETPure Genius Protein Launches Protein + Fiber Shots To Fill Nutrition Gap](https://longbridge.com/en/news/297654126.md)
- [08:11 ETPenguin Ai Launches Intelligent Medical Coding and Intelligent Revenue Cycle Management Solutions in AWS Marketplace](https://longbridge.com/en/news/297650438.md)
- [06:05 ETKarmanos Now Offers FDA-Approved Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancer](https://longbridge.com/en/news/297497971.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**